Search results
Buckingham Palace opens room to Queen Elizabeth's famous balcony photos. What's the catch?
USA TODAY via Yahoo News· 5 days agoPrincess Kate makes public return for King Charles III's birthday amid cancer treatments "For the...
What was the Battle of the Boyne, and why is it only a bank holiday in one part of the UK?
Evening Standard via Yahoo News· 3 days agoThe celebration also sees bonfires get lit and families attend community events. The day is a...
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Zacks via Yahoo News· 3 days agoKazia (KZIA) surges after positive data from a phase II/III study on its lead pipeline drug in...
2024 Emmys Supporting Actor Limited/Movie Predictions
Variety via Yahoo News· 4 days agoVariety Awards Circuit section is the home for all awards news and related content throughout the...
Pharma Stock Roundup: LLY to Buy Morphic, PFE Advances Obesity Drug Development
Zacks via Yahoo News· 3 days agoEli Lilly (LLY) offers to acquire Morphic Therapeutics for $3.2 billion. Pfizer (PFE) selects a...
‘Beverly Hills Cop’ Soars Up the Streaming Chart — But It Can’t Beat ‘House of the Dragon’ | Charts
The Wrap via Yahoo News· 4 days agoShowtime's “Your Honor” spends its fifth week in the Streaming Top 10 after landing on Netflix The...
‘Longlegs’ Review: Nicolas Cage Manages To Top His Twisted Legacy With The Most Extreme & Creepy...
Deadline via Yahoo News· 6 days agoWriter-director Osgood Perkins is aiming straight at his celebrated father’s status at the top of...
Brittany Mahomes Shares First Meal in U.S. After Europe Trip with Husband Patrick: ‘Don’t Say...
People via Yahoo News· 5 days agoBrittany and her husband Patrick Mahomes recently returned from visiting countries including Spain,...
Zacks.com featured highlights GIII Apparel Group, Caleres, KB Home, MRC Global and Greenbrier
Zacks via Yahoo News· 4 days agoHere are five of the 17 stocks that qualified after the screening: G-III Apparel is a manufacturer,...
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study
Zacks via Yahoo News· 3 days agoTop-line 52-week data from the phase II study is expected in late 2024. Amgen is planning to conduct...